The Executive Committee of the University of Montreal Hospital Research Centre (CRCHUM) has announced the appointment of Dr. Christian Stapf as Associate Scientific Director for Clinical Research.
Dr Stapf will begin his mandate on April 15th, 2017. He is replacing Dr. Paul Hébert, who has held this position on an interim basis for the last two years.
“I want to sincerely thank Dr. Paul Hébert for successfully strengthening our clinical research expertise. With the opening of the new CHUM and the move of the clinical research teams, it becomes even more critical to integrate research with patient care and teaching. I am convinced that Dr. Christian Stapf will rise to the challenge,” said Dr. Vincent Poitout, Director of the CRCHUM.
A world-renowned vascular neurologist, Dr. Stapf was recruited in September 2015 as a scientist and neurologist at the CHUM, and as Full Professor at the Department of Neuroscience at the Université de Montréal’s Faculty of Medicine. Prior to that, he had been the director of the Acute Neurovascular Unit at the Hôpital Lariboisière public hospital (APHP) in Paris.
Dr. Stapf’s main mandate is to establish a clinical research development plan, and more specifically to:
- Promote the development of research projects that will have an impact on clinical excellence and the development of communities of practice;
- Establish a common methodological infrastructure to support patient-centered research activities;
- Encourage the engagement of clinical departments and services in the development of clinical research at the CHUM;
- Plan the recruitment of new clinical researchers and support their career development.
“I am very enthusiastic about starting my new mandate in the dynamic context of a major restructuring,” said Dr. Stapf.
“The New CHUM project is a rare opportunity, allowing us to create an interface between clinical medicine and research methodologies in order to transform our day-to-day routine into a laboratory of the future,” he added.
Christian Stapf – M.D. - biography
Christian Stapf received his medical degree from the Freie Universität Berlin (Germany) in 1995, before completing his residency in neurology at the Campus Benjamin Franklin de la Charité - Universitätsmedizin Berlin. He pursued a postdoctoral neurovascular fellowship at the Neurological Institute of New York, which is part of Columbia University (U.S.A.). In 2003, he accepted an appointment as a clinical neurologist at the Hôpital Lariboisière public hospital (APHP) in Paris (France), a position which he held while teaching as a full professor of neurology at the Université Diderot – Sorbonne Paris Cité (France) and as an adjunct assistant professor of neurology at Columbia University (U.S.A.). He has been in Canada since 2015, working as a researcher and neurologist at the University of Montreal Hospital Centre (CHUM) and as a full professor in the Université de Montréal’s Department of Neuroscience.
His research interests focus on the neurological and epidemiological aspects of cerebral vascular malformations, as well as other predispositions to intracranial hemorrhaging. During his career, Dr. Christian Stapf made a name for himself in his role as the European coordinator and principal co-investigator of major clinical trials that have had an impact on patient management worldwide. He has also published many articles in his field. Dr. Stapf received the Young Investigator Award from the European Stroke Conference in 2000, and the Robert G. Siekert New Investigator Award in Stroke from the American Heart Association and from the American Stroke Association the following year. In 2016, he had the honour of receiving the William L. Young/Allison Raaen Lectureship from the University of California San Francisco (UCSF)’s Center for Cerebrovascular Research.